Assessment of heterogeneity among participants in the Parkinson’s Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study (DOI: 10.1016/S1474-4422(23)00109-6)
Published May 2023

Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson’s Disease in the DeNovo Parkinson (DeNoPa) Cohort (DOI: 10.1002/mds.29329)
Published April 2023

Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid (DOI: 10.1038/s41596-022-00787-3)
Published April 2023

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease (DOI: 10.1186/s40478-021-01282-8)
Published November 2021

Seed Amplification Assay to Diagnose Early Parkinson’s and Predict Dopaminergic Deficit Progression (DOI: 10.1002/mds.28715)
Published October 2021

Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure (DOI: 10.1002/ana.26089)
Published June 2021

Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies (DOI: 10.1002/ana.25824)
Published September 2020

Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy (DOI: 10.1038/s41586-020-1984-7)
Published February 2020

Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson’s disease (DOI: 10.1002/mds.27646)
Published April 2019

Detection of Misfolded α-Synuclein Aggregates in Cerebrospinal Fluid by the Protein Misfolding Cyclic Amplification Platform (DOI: 10.1007/978-1-4939-9124-2_4)
Published February 2019

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid (DOI: 10.1001/jamaneurol.2016.4547)
Published February 2017